Systemic absorption with complications during topical tacrolimus treatment for orofacial Crohn disease.
Russell
R K
RK
Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh, Scotland, UK. richardkrussell71@hotmail.com
Richardson
N
N
Wilson
D C
DC
D000042:Absorption; D000287:Administration, Topical; D000293:Adolescent; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006562:Herpes Zoster / Q000139:chemically induced; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016559:Tacrolimus / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D016559:Tacrolimus